GLP-1 agonists do not require dose adjustment for renal function, but improved kidney perfusion from GLP-1-driven weight loss and blood pressure reduction may restore metformin eligibility over time
For urgent or patient-specific access, our NPS coordination team checks prescription documents, import authorization, proforma requirements, and shipping feasibility
Kishimoto S, Kinoshita Y, Matsumoto T, Maruhashi T, Kajikawa M, Matsui S, Hashimoto H, Takaeko Y, Kihara Y, Chayama K, Goto C, Mohamad Yusoff F, Nakashima A, Noma K, Higashi Y (2019) Effects of the dipeptidyl peptidase 4 inhibitor alogliptin on blood pressure in hypertensive patients with type 2 diabetes mellitus
However, in this study, the production of ROS did not show a significant relationship with the concentration of OCPs
This makes it an attractive compound for researchers studying metabolic dysfunction-associated steatotic liver disease, hepatic insulin sensitivity, and lipid oxidation pathways